greenleafinsights

Scaling cannabis production isn’t just about output. It’s about process, consistency, and building systems that actually hold up under pressure. In cannabis, scaling sounds simple: grow more, […]

President Trump signed an executive order on April 18 directing the FDA to fast-track review of psychedelic therapies and committing $50 million to ibogaine research. The […]

As federal cannabis rescheduling looms on the horizon and more states across the country begin rolling out regulations for legal psychedelic therapy, health officials have increasingly […]

From home labs and deadly butane blasts to solventless rosin, police raids, and a legal gray zone, Spain is entering a more potent and more volatile […]

Legal cannabis operators paid $2.24 billion in excess federal taxes in 2025. The illicit market paid zero. That is not a coincidence. That is policy. What […]

Jimmy John’s Dream Rotation campaign doesn’t wink at cannabis culture. It hires Cheech Marin, lets him argue with a sandwich and makes Kal Penn’s ideal 4/20 […]

A survey of more than 1,100 people with suspected or diagnosed CHS offers one of the clearest looks yet at the condition, including a notable finding: […]

The ending feels almost tragic, especially for a story that, when it came to adult-use cannabis, once seemed destined to succeed. In 2022, Thailand made history […]

A decade in, one of New York’s most important cannabis gatherings is doubling down. New York’s cannabis industry doesn’t have many constants. Markets shift, regulations change, […]